The global mobile gamma cameras market is poised for remarkable growth, with projections indicating a valuation of USD 59.5 billion by the end of 2023. This dynamic expansion is driven by a growing emphasis on patient-centric care, anticipating a robust compound annual growth rate (CAGR) of 4.2% from 2023 to 2033, potentially reaching USD 89.8 billion by the end of the forecast period.
The increasing demand for mobile gamma cameras reflects the healthcare sector’s shift toward flexible, patient-focused diagnostic solutions. These advanced imaging devices are critical for delivering real-time, high-resolution images that enhance diagnostic accuracy and treatment planning.
Several key factors are contributing to this market trajectory. First, ongoing advancements in medical imaging technologies are enhancing the efficiency and accessibility of mobile gamma cameras. Additionally, the transition towards outpatient care and home-based diagnostic services is driving the need for portable imaging solutions, offering convenience and reducing patient travel to healthcare facilities.
As the market evolves, stakeholders are prioritizing innovation and technological advancements to meet the growing demands of healthcare providers and patients. The commitment to enhancing diagnostic accuracy and patient care positions the global mobile gamma cameras market for significant growth, mirroring broader trends towards personalized and accessible medical solutions.
Mobile gamma cameras are increasingly used alongside other imaging modalities such as CT (Computed Tomography) and MRI (Magnetic Resonance Imaging) to deliver comprehensive diagnostic assessments. Their integration with electronic health records (EHRs) and Picture Archiving and Communication Systems (PACS) further improves data management and accessibility, significantly enhancing their overall utility.
The application of mobile gamma cameras extends to post-treatment monitoring in nuclear medicine therapies, including radioiodine therapy for thyroid disorders. This expanded use is bolstered by the need for preparedness against potential health crises or bioterrorism threats, leading to the establishment of mobile medical units equipped with essential diagnostic tools like mobile gamma cameras.
Market Insights:
- The global mobile gamma cameras market was valued at USD 56.3 billion by the end of 2022.
- From 2018 to 2022, market demand grew at a CAGR of 4.0%.
- India held a market share of 15.0% in 2022.
- The hospitals segment accounted for a 41.0% market share in 2022.
- From 2023 to 2033, the market is projected to grow at a CAGR of 4.2%.
- By 2033, the market value is expected to reach USD 89.8 billion.
Future Prospects:
The burgeoning growth of telehealth services, including telemedicine and teleradiology, is anticipated to significantly contribute to the expansion of the mobile gamma cameras market in the near future, according to FMI analysts.
Get the Latest on Mobile Gamma Cameras: Our Full Report Highlights Key Trends and Insights!
Competitive Landscape:
Key players in the mobile gamma cameras market include Digirad Corporation, DDD-Diagnostic A/S, Dilon Technologies, Inc., Spectrum Dynamics Medical, GAEDE Medizinsysteme GmbH, Beijing Hamamatsu Photon Techniques Inc., MIE America, Mediso, CLERAD, and CardiArc.
Recent Developments:
- 2023: Nuclear Fields launched the Gamma-Boy, a portable and affordable mobile gamma camera designed for diverse settings including hospitals, clinics, and research laboratories.
- 2022: Siemens Healthineers introduced the Symbia Intevo Bold, a high-resolution mobile gamma camera intended for SPECT and PET nuclear medicine imaging procedures.
- 2021: Dilon Technologies unveiled the Ranger Vision 2.0, a lightweight and compact mobile gamma camera for use in hospitals, clinics, and ambulances. Gamma Medica also launched the LumaGEM 360, a high-resolution mobile gamma camera for SPECT and PET imaging.
Segmentation Analysis:
- Product Type: Single Head, Double Head, Triple Head, Hand Held
- Indication: Cardiac Imaging, Breast Imaging, Hepatobiliary Imaging, GI Imaging, Renal Imaging, Brain Imaging, Others
- End-User: Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes, Specialized Clinics
- Region: North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia, The Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube